EWM
CVS icon

Empirical Wealth Management’s CVS Health CVS Stock Holding History

Empirical Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$994K Sell
9,611
-4,079
-30% -$364K 0.01% 408
2026
Q1 		$983K Buy
13,690
+4,639
+51% +$357K 0.02% 363
2025
Q4 		$718K Buy
9,051
+623
+7% +$49.1K 0.01% 407
2025
Q3 		$635K Buy
+8,428
New +$578K 0.01% 411
2025
Q2 		– Sell
-3,385
Closed -$229K – 699
2025
Q1 		$229K Buy
+3,385
New +$203K 0.01% 575
2024
Q2 		– Sell
-2,911
Closed -$232K – 566
2024
Q1 		$232K Buy
2,911
+202
+7% +$15.4K 0.01% 482
2023
Q4 		$214K Buy
+2,709
New +$193K 0.01% 463
2023
Q3 		– Sell
-7,553
Closed -$522K – 473
2023
Q2 		$522K Sell
7,553
-75,111
-91% -$5.34M 0.02% 297
2023
Q1 		$6.14M Sell
82,664
-11,361
-12% -$953K 0.27% 71
2022
Q4 		$8.76M Buy
94,025
+7,970
+9% +$769K 0.41% 50
2022
Q3 		$8.21M Buy
86,055
+19,999
+30% +$1.98M 0.43% 46
2022
Q2 		$6.12M Buy
66,056
+49,339
+295% +$4.82M 0.32% 60
2022
Q1 		$1.69M Sell
16,717
-727
-4% -$76.4K 0.08% 148
2021
Q4 		$1.8M Sell
17,444
-49
-0.3% -$4.53K 0.09% 146
2021
Q3 		$1.48M Buy
17,493
+2,167
+14% +$182K 0.08% 145
2021
Q2 		$1.28M Buy
15,326
+2,678
+21% +$219K 0.08% 159
2021
Q1 		$951K Buy
12,648
+487
+4% +$35.5K 0.08% 161
2020
Q4 		$831K Buy
12,161
+3,566
+41% +$232K 0.06% 174
2020
Q3 		$502K Buy
8,595
+1,345
+19% +$83.7K 0.04% 214
2020
Q2 		$471K Buy
+7,250
New +$457K 0.04% 220

Other funds holding CVS

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Empirical Wealth Management's CVS Position: Q2 2026 in Review

Empirical Wealth Management reduced its CVS Health (CVS) stake by 30% in Q2 2026, selling an estimated $364K and leaving 9,611 shares worth $994K. The position accounts for 0.01% of the portfolio, ranked #408.

Empirical Wealth Management first reported a position in CVS in Q2 2020 and has held it in 20 quarters since. The position peaked at $8.76M in Q4 2022. 937 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Empirical Wealth Management held 9,611 shares of CVS Health worth $994K as of Q2 2026.
  • Empirical Wealth Management sold 4,079 CVS Health shares in Q2 2026, an estimated $364K.
  • CVS Health made up 0.01% of Empirical Wealth Management's portfolio in Q2 2026, its #408 holding.
  • Empirical Wealth Management first reported a position in CVS Health in Q2 2020 and has held it in 20 quarters since.
  • Empirical Wealth Management's CVS Health position peaked at $8.76M in Q4 2022.
  • 937 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Empirical Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.